tiprankstipranks
Trending News
More News >
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
US Market

SOPHiA GENETICS (SOPH) Financial Statements

Compare
107 Followers

SOPHiA GENETICS Financial Overview

SOPHiA GENETICS's market cap is currently $293.78M. The company's EPS TTM is $-0.28; its P/E ratio is -3.99; SOPHiA GENETICS is scheduled to report earnings on March 3, 2026, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 77.27M$ 65.17M$ 62.37M$ 47.56M$ 40.45M
Gross Profit$ 47.81M$ 43.94M$ 42.91M$ 31.25M$ 25.22M
Operating Income$ -70.92M$ -66.57M$ -74.83M$ -87.82M$ -71.49M
EBITDA$ -61.40M$ -50.76M$ -69.57M$ -81.38M$ -69.24M
Net Income$ -79.00M$ -62.49M$ -78.98M$ -87.45M$ -73.67M
Balance Sheet
Cash & Short-Term Investments$ 70.29M$ 80.23M$ 123.25M$ 178.61M$ 265.32M
Total Assets$ 163.46M$ 155.31M$ 206.16M$ 243.84M$ 320.17M
Total Debt$ 63.02M$ 30.03M$ 18.60M$ 16.74M$ 13.06M
Net Debt$ -7.27M$ -50.20M$ -104.65M$ -144.56M$ -179.90M
Total Liabilities$ 116.31M$ 58.82M$ 54.71M$ 43.71M$ 44.77M
Stockholders' Equity$ 47.15M$ 96.49M$ 151.44M$ 200.13M$ 275.40M
Cash Flow
Free Cash Flow$ -38.59M$ -51.00M$ -57.80M$ -80.47M$ -64.61M
Operating Cash Flow$ -38.01M$ -42.82M$ -48.58M$ -70.09M$ -57.94M
Investing Cash Flow$ -10.51M$ -8.18M$ 8.32M$ 41.97M$ -56.93M
Financing Cash Flow$ 34.13M$ 11.59M$ -2.82M$ -1.57M$ 237.77M
Currency in USD

SOPHiA GENETICS Earnings and Revenue History

SOPHiA GENETICS Debt to Assets

SOPHiA GENETICS Cash Flow

SOPHiA GENETICS Forecast EPS vs Actual EPS